The UK Government has announced a £40m grant to drive brain cancer research under the Tessa Jowell Brain Cancer Research Mission.

Tessa Jowell, a British politician, died on 12 May this year after suffering from brain cancer.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

11,400 people in the UK are affected by brain tumours each year. Of the total patients, only 14% survive for ten years or more.

The research programme is in line with Jowell’s goal to enhance care and outcomes for patients suffering from the disease.

Health Minister Lord James O’Shaughnessy said: “We are deeply saddened by this loss. Tessa Jowell did more than anyone to shine a light on the need to improve research and care for people with brain cancer.

“We hope the work will boost life-saving research and transform brain cancer care in the way that Tessa called for.”

“It is a great privilege and honour to take forward this work, which we hope will boost life-saving research and transform brain cancer care in the way that Tessa called for.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The project will initially involve an investment of £65m, of which £25m will be contributed by Cancer Research UK, with plans to increase the funding each year based on research proposals.

The research fund will be used to support new clinical commitments such as the launch of a dye developed to identify tumours during brain cancer surgery. At present, the dye is only available in 50% of England’s brain cancer centres.

The commitments also include the advancement of adaptive trials designed to simultaneously assess multiple treatments to speed up the process.

The UK Government will host a new Tessa Jowell global symposium, which will bring together the clinical, scientific and academic experts on brain cancer to identify gaps, best practice and priorities in research.

Pharmaceutical Technology Excellence Awards - Nominations Closed

Nominations are now closed for the Pharmaceutical Technology Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Awarded the 2025 Pharmaceutical Technology Excellence Award for Business Expansion in Integrated Manufacturing, Upperton Pharma Solutions is rapidly expanding its UK GMP and sterile manufacturing footprint. Find out how Upperton’s integrated CDMO model helps pharma companies move from early development to clinical and niche commercial supply with fewer handovers and faster timelines.

Discover the Impact